Challenges for Intellectual Property Management of HIV Vaccine-Related Research and Development: Part 2, The Canadian Context

• Author(s) / Creator(s)

  • Patten, San
  • Bubela, Tania
  • Knowles, Lori

• This paper builds upon the key issues identified in Part One of this series of two papers on“Challenges for Intellectual Property Management of HIV Vaccine-Related Research and Development” [hereinafter, Part One]. Following that review of the global literature and consultations with international experts, we consulted with representatives from the CHVI and developed sector-specific interview guides for academic researchers, government, and industry representatives in Canada. We conducted individual or group interviews with key informants in Canada, including CHVI representatives, experts in intellectual property law, management and ethics, as well as academic and private sector HIV vaccine researchers. Here, we present the conclusions from those interviews, a discussion of key concerns, and potential solutions.

• Date created

  2014-11-14

• Subjects / Keywords

  • AIDS Vaccines
  • Research--economics
  • Intellectual Property

• Type of Item

  Research Material

• DOI

  https://doi.org/10.7939/R39G5GF7C

• License

  © 2008 Health Law Institute, University of Alberta. This version of this article is open access and can be downloaded and shared. The original authors and source must be cited.